ATAI Life Sciences NV
ATAI3.787USD
+0.017+0.44%
取引時間 （ET）15分遅れの株価
910.42M時価総額
損失額直近12ヶ月PER
詳細情報 ATAI Life Sciences NV 企業名
Atai Beckley NV, formerly ATAI Life Sciences NV, is a clinical-stage biopharmaceutical company. The Company focused on developing treatments for mental health disorders. The Company's pipeline includes psychedelic and non-psychedelic compounds targeting depression, anxiety, and other unmet needs in psychiatry.
ATAI Life Sciences NVの企業情報
企業コードATAI
会社名Atai Beckley NV
上場日Jun 18, 2021
最高経営責任者「CEO」Rao (Srinivas G)
従業員数54
証券種類Ordinary Share
決算期末Jun 18
本社所在地Prof. J.H.Bavincklaan 7
都市AMSTELVEEN
証券取引所NASDAQ OMX - NASDAQ BASIC
国Netherlands
郵便番号1183 AT
電話番号31207932536
ウェブサイトhttps://www.atai.com/
企業コードATAI
上場日Jun 18, 2021
最高経営責任者「CEO」Rao (Srinivas G)
ATAI Life Sciences NVの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Glenn Frank Short, Ph.D.
Dr. Glenn Frank Short, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
42.33K
+19339.00%
Ms. Andrea Heslin Smiley
Ms. Andrea Heslin Smiley
Independent Supervisory Director
Independent Supervisory Director
4.67K
--
Mr. Christian Angermayer
Mr. Christian Angermayer
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
--
Ms. Sabrina Martucci Johnson
Ms. Sabrina Martucci Johnson
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Amir Kalali
Dr. Amir Kalali
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Srinivas Rao, M.D., Ph.D.
Dr. Srinivas Rao, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Interim Managing Director
Chief Executive Officer, Co-Founder, Interim Managing Director
--
--
Ms. Anne Johnson
Ms. Anne Johnson
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Gerd G. Kochendoerfer
Dr. Gerd G. Kochendoerfer
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Kevin James Craig, M.D.
Dr. Kevin James Craig, M.D.
Chief Medical Officer
Chief Medical Officer
--
--
Dr. Scott N. Braunstein, M.D.
Dr. Scott N. Braunstein, M.D.
Independent Supervisory Director
Independent Supervisory Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Dr. Glenn Frank Short, Ph.D.
Dr. Glenn Frank Short, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
42.33K
+19339.00%
Ms. Andrea Heslin Smiley
Ms. Andrea Heslin Smiley
Independent Supervisory Director
Independent Supervisory Director
4.67K
--
Mr. Christian Angermayer
Mr. Christian Angermayer
Chairman of the Supervisory Board
Chairman of the Supervisory Board
--
--
Ms. Sabrina Martucci Johnson
Ms. Sabrina Martucci Johnson
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Amir Kalali
Dr. Amir Kalali
Independent Supervisory Director
Independent Supervisory Director
--
--
Dr. Srinivas Rao, M.D., Ph.D.
Dr. Srinivas Rao, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Interim Managing Director
Chief Executive Officer, Co-Founder, Interim Managing Director
--
--
収益内訳
会社から関連データがまだ開示されていません。
会社から関連データがまだ開示されていません。
事業別
地域別
会社から関連データがまだ開示されていません。
株主
更新時刻: Sat, Feb 7
更新時刻: Sat, Feb 7
株主統計
種類
株主統計
株主統計
比率
Apeiron Investment Group Ltd
15.20%
Feilding-Mellen (Cosmo)
2.11%
Adage Capital Management, L.P.
1.50%
Brand (Florian Olaf)
1.39%
Morgan Stanley Investment Management Inc. (US)
0.89%
他の
78.91%
株主統計
株主統計
比率
Apeiron Investment Group Ltd
15.20%
Feilding-Mellen (Cosmo)
2.11%
Adage Capital Management, L.P.
1.50%
Brand (Florian Olaf)
1.39%
Morgan Stanley Investment Management Inc. (US)
0.89%
他の
78.91%
種類
株主統計
比率
Family Office
15.22%
Hedge Fund
4.58%
Investment Advisor
3.86%
Individual Investor
3.69%
Investment Advisor/Hedge Fund
1.88%
Research Firm
1.23%
Private Equity
0.39%
Endowment Fund
0.20%
Venture Capital
0.05%
他の
68.90%
機関投資家保有株
更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
246
44.37M
12.22%
+3.53M
2025Q3
249
45.57M
19.55%
+12.66M
2025Q2
225
29.96M
14.58%
+6.94M
2025Q1
223
23.03M
12.83%
-2.41M
2024Q4
236
15.60M
13.86%
+2.09M
2024Q3
236
13.53M
16.71%
-545.79K
2024Q2
246
14.10M
16.43%
-259.20K
2024Q1
244
14.41M
17.26%
-14.24M
2023Q4
251
15.93M
17.75%
-1.57M
2023Q3
259
17.69M
19.30%
-562.50K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Apeiron Investment Group Ltd
55.21M
15.2%
+14.20K
+0.03%
Oct 20, 2025
Feilding-Mellen (Cosmo)
7.70M
2.12%
+7.70M
--
Nov 05, 2025
Adage Capital Management, L.P.
5.43M
1.5%
--
--
Sep 30, 2025
Brand (Florian Olaf)
5.04M
1.39%
-250.00K
-4.73%
Sep 15, 2025
Morgan Stanley Investment Management Inc. (US)
3.23M
0.89%
+1.39M
+75.10%
Sep 30, 2025
Citadel Advisors LLC
2.58M
0.71%
+1.40M
+118.39%
Sep 30, 2025
Ally Bridge Group NY LLC
2.29M
0.63%
+2.29M
--
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
2.18M
0.6%
+2.11M
+2973.34%
Dec 31, 2025
Candriam Luxembourg S.A.
1.72M
0.47%
--
--
Nov 30, 2025
ARK Investment Management LLC
2.02M
0.56%
+457.76K
+29.31%
Sep 30, 2025
詳細を見る
関連ETF
更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
AdvisorShares Psychedelics ETF
17.55%
ARK Genomic Revolution ETF
1.6%
Invesco NASDAQ Future Gen 200 ETF
0.69%
Even Herd Long Short ETF
0.14%
Avantis US Small Cap Equity ETF
0.08%
First Trust IPOX Europe Equity Opportunities ETF
0.06%
SPDR S&P International Small Cap ETF
0.05%
Fidelity Nasdaq Composite Index ETF
0%
ProShares Ultra Nasdaq Biotechnology
0%
Avantis US Equity ETF
0%
詳細を見る
AdvisorShares Psychedelics ETF
比率17.55%
ARK Genomic Revolution ETF
比率1.6%
Invesco NASDAQ Future Gen 200 ETF
比率0.69%
Even Herd Long Short ETF
比率0.14%
Avantis US Small Cap Equity ETF
比率0.08%
First Trust IPOX Europe Equity Opportunities ETF
比率0.06%
SPDR S&P International Small Cap ETF
比率0.05%
Fidelity Nasdaq Composite Index ETF
比率0%
ProShares Ultra Nasdaq Biotechnology
比率0%
Avantis US Equity ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
